32nd Hemophilia Symposium Hamburg 2001
| Other Authors: | , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Berlin, Heidelberg
Springer Berlin Heidelberg
2003, 2003
|
| Edition: | 1st ed. 2003 |
| Subjects: | |
| Online Access: | |
| Collection: | Springer Book Archives -2004 - Collection details see MPG.ReNa |
Table of Contents:
- Isolated molecular Defects of von Willebrand Factor Binding to Collagen do not correlate with Bleeding Symptoms
- Effects of Tissue Factor Pathway Inhibitor and Antithrombin on Thrombin Generation in Tissue Factor-activated Cord Plasma
- Early and Rapid Diagnosis of acute TTP by Measuring Activity of von-Willebrand Factor Cleaving Metalloprotease (ADAMTS13): A Case Report
- Prions and the Safety of Plasma Proteins: Preventive Measures and Research Activities
- VI. Poster
- a) Clinic and Casuistic
- Transmission of Parvovirus B19 by Heat-treated Coagulation Factor Concentrates
- Course of severe Hemophilia A. Successful Immune Tolerance Therapy (ITT) ten Years after Inhibitor Development
- Increased Resistance to activated Protein C and Protein C Deficiency in the same Family
- A Life-threatening Cardiomyopathy following Port-a-Cath Infection under Immune Tolerance Therapy
- Therapy and Prophylaxis of Bleeding Symptoms in a Patient with Acquired Factor X-Deficiency due to Systemic Amyloidosis (AL-Amyloidosis)
- Is there a Correlation between vWF-cleaving Protease-Activity, vWF:Ag, Clinical Course and Number of Relapses in 15 Patients with TTP?
- Life-Threatening Hemorrhage in a Patient with Red Cell Antibodies — Effective Blood Coagulation with rFVIIa
- Liver Transplantation in a HIV/HCV coinfected Hemophilia A Patient
- Dysfibrinogenemia following after Snake Bite
- Bleeding Complications following Tooth Extraction in a Hemophilia A Patient with Inhibitor — A Case Report
- Cerebral Sinus Thrombosis: Recanalization after intravenous Dalteparin Administration
- b) Hemophilia and Hemorrhagic Disorders
- Treatment of FVIII-Autoantibodies by Protein A-Based Immunoadsorption and Immunosuppression: A Regimen without FVIII Substitution
- Factor XI Deficiency caused by a hitherto unknown Mutation in the Factor XI Gene
- An Innovative Approach to Teach and Learn Diagnostic Skills and Therapeutical Management of Coagulation Disorders: CAMPUS — an Interactive, Computer- and Case-Based Program
- Expression of Protease-activated Receptors in Neuroblastoma Cells
- Adenovirus-mediated regulatable Expression of human Factor IX in vitro and in vivo
- III. Hemophilia
- a) Orthopedics
- Experiences with MRI Examination of the Joints of hemophilic Children
- Rhenium-186 Hydroxyethylidenediphosphonate (186Re HEDP) — A novel Treatment for hemophilic Arthropathies?
- b) Monitoring of Substitution Therapy
- Monitoring of Anticoagulant Therapy with the Endogenous Thrombin Potential
- IV. Pediatric Hemostaseology
- First thromboembolic Onset in Children carrying either the heterozygeous FV G1691A Mutation or the Prothrombin G20210A Variant
- UFH Bolus Administration in Comparison to subcutaneous Low Molecular Weight Heparin in pediatrie cardiac Catheterization
- Incidence of Inhibitor Development in consecutively recruited severe Hemophilia A and B Patients — a retrospective Single Centre Study
- V. Free Lectures
- FV Inhibitor and Anti-Phospholipid Antibodies after Treatment with Ciprofloxacin
- I. Epidemiology
- HIV Infection and Causes of Death in Patients with Hemophilia in Germany (Year 2000/2001 Survey)
- Hemophilia 2001 — The Annual Survey of the Austrian Hemophilia Centers
- Epidemiology of Hemophilia in Switzerland: A first Insight in the Data Base achieved by the Medical Committee of the Swiss Hemophilia Association
- Overall Blood Supply Strategy with Regard to vCJD
- II. Genetic Diagnosis of Clotting Disorders
- a) Human Genome Project
- 11 novel Mutations in the Factor VIII encoding Gene lead to severe or moderate Hemophilia A
- b) Register and Genetic Diagnosis
- Molecular Analysis of Hemophilia B: »Greifswald Registry FIX Deficiency (Hemophilia B)«
- Gly222Asp and Ser379Lys — Novel Factor X Gene Mutations in severe FX Deficiency — Greifswald Registry of Factor X congenital Deficiency
- c) Gene Therapy
- Hematopoietic Stem Cells as Targets for Gene Therapy of Hemophilia A
- Inactivation of Animal Factor VIII by human Factor VIII Inhibitors: Investigation of Plasma from Patients with Inhibitors in congenital Hemophilia A and from Patients with acquired Hemophilia A
- Factor VIII:C Measurement — Comparison between Chromogenic and Coagulometric Methods in Hemophilia A — Patients with the B Domain-depleted Recombinant F VIII-Preparation ReFacto
- Functional Assessment of fibrinolytic Resistance in whole Blood
- e) Miscellaneous
- Quality Control of Platelet Concentrates during Storage Using Different Forms of Agitation Measuring the Platelet Activation
- Platelet Activation before and after Cryopreservation of Platelet Concentrates with a New Storage Solution
- Flow Cytometric Measurement of CD34+ Cells: How reliable are absolute Cell Counts generated by the Integration of Beads?
- Polymorphisms in FV Gene associated with FV Deficiency — First Results
- Influence of Phospholipids of the Platelet Membrane of Newborns on the Thrombin Generation
- Socio-economic Evaluation of Hemophilia Assistance
- Aspects regarding Locomotor Rehabilitation of Hemophiliacs
- c) Thrombophilic Disorders
- Prothrombin and Factor VII Genotypes and Phenotypes in healthy Individuals. Results from the Lugen Study
- Factor V Leiden and Other thrombotic risk factors in CHD and myocardial Infarction
- In vitro Effects of combined Administration of Epitifibatide and Anticoagulants on Thrombin induced Platelet Aggregation after high versus low Coagulant Activation of Platelet Rich Plasma
- Cardiac and cerebral Manifestations of the Antiphospholipid Syndrome
- d) Diagnosis
- Inactivation of Animal Factor VIII by human Factor VIII Inhibitors: Special Methodological Features in Performing the Factor VIII Assay and the Bethesda Assay